Development and Validation of a New Eco-Friendly HPLC-PDA Bioanalytical Method for Studying Pharmacokinetics of Seliciclib

<i>Background and Objectives:</i> Seliciclib (SEL) is the first selective, orally bioavailable potential drug containing cyclin-dependent kinase inhibitors. Preclinical studies showed antitumor activity in a broad range of human tumor xenografts, neurodegenerative diseases, renal dysfunc...

Full description

Bibliographic Details
Published in:Medicina
Main Authors: Reem M. Abuhejail, Nourah Z. Alzoman, Ibrahim A. Darwish
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Subjects:
seliciclib
cyclin-dependent kinase inhibitors
HPLC-PDA
pharmacokinetic study
therapeutic drug monitoring
green analytical chemistry
Online Access:https://www.mdpi.com/1648-9144/60/10/1686

Internet

https://www.mdpi.com/1648-9144/60/10/1686

Similar Items